Reliable testing of product inspection systems with Mettler-Toledo Safeline
Improved testing samples ensure compliance with due diligence
By placing test samples on their food production lines or within their products, manufacturers can ensure that their product inspection systems are operating correctly and offering optimum contaminant detection. Regular testing of metal detectors and x-ray inspection systems can prevent adverse trends in contaminant detection before they become a problem, the company says.
The new test samples have a robust casing material, which protects products from the contaminant inside and enables repeated use. Made with materials approved by the US Food and Drug Administration (FDA), manufacturers can be confident that the samples will not contaminate their food products with fragments from damaged casing, ink or glue unsuitable for human consumption. The test samples are available in a range of sizes to allow comprehensive testing for a number of product inspection systems.
‘Product recalls from undetected contamination can be costly and damaging both to the consumer and to the manufacturer. By ensuring your product inspection system is operating correctly, you can safeguard the well-being of the consumer, protect your profits and ultimately your brand reputation,’ said Jonathan Richards, marketing manager, Mettler-Toledo Safeline.
The test samples follow an internationally recognised colour coding system to enable easy identification of the contaminant. For metal detection, ferrous samples are marked in red, brass in yellow, stainless steel in blue and aluminium in green. For x-ray samples, soda lime glass, PVC and Teflon are marked in black.
The test cards are suitable for all metal detection and x-ray machines including Mettler-Toledo Safeline’s product inspection systems.
You may also like
Digital
Shaping the future of ATMPs: tailored automation and advanced technologies for the next decade
Read moreIf history is to repeat itself, the next 10 years will see significant activity regarding the automation of advanced therapy medicinal products (ATMPs). Having said that, however, one size is unlikely to fit all. Several core solutions tuned to specific therapies are likely to appear. By Dr Dave Seaward
Trending Articles
You may also like
Digital
Shaping the future of ATMPs: tailored automation and advanced technologies for the next decade
If history is to repeat itself, the next 10 years will see significant activity regarding the automation of advanced therapy medicinal products (ATMPs). Having said that, however, one size is unlikely to fit all. Several core solutions tuned to specific therapies are likely to appear. By Dr Dave Seaward
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Design & Build
How Germfree is responding to US policy shifts with cleanroom and digital facility expansion
Carol Houts, Chief Strategy Officer at Germfree talks to Sophie Bullimore about the US-based modular expert’s expansion into stick-built cleanrooms, how the company is responding to US policy shifts, and how the innovative team is making a move on the need for digital and automated facilities